Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Mesh study follows patients for years after prolapse surgery

NCT ID NCT06296316

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 39 women who had surgery for pelvic organ prolapse using Restorelle mesh. The goal was to track safety and how well the mesh worked over 5 to 8 years after surgery. No new treatment was given—just routine check-ups to see if any further surgery was needed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

39 people

The number who actually took part.

Started

Nov 2023

Finished

Nov 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult female patients presenting with apical pelvic organ prolapse which is clinically indicated for a surgical treatment with Restorelle mesh

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female patient of at least 18 years old * Patient presenting apical pelvic organ prolapse and being eligible to surgical treatment * Surgeon having decided to treat the patient with a Restorelle mesh as per its CE mark indication and IFU, before patient inclusion * Patient having received appropriate information and counselling before mesh implantation * Patient has been provided written informed consent Exclusion Criteria: * Patient currently pregnant or breastfeeding * Patient being deprived of liberty by a judicial or administrative decision, or who is under a measure of legal protection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Genital prolapse are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH La Rochelle

    La Rochelle, 17019, France

  • CH de Saintonge

    Saintes, 17108, France

  • CHU Pellegrin

    Bordeaux, 33076, France

  • Clinique Bon Secours

    Le Puy-en-Velay, 43000, France

  • Institut Mutualiste Montsouris

    Paris, 75014, France

  • Polyclinique de la Baie

    Avranches, Choisir Une Région, 50300, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.